myelodysplastic syndromes (mds)
Showing 1 - 25 of 34
Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States
Recruiting
- Acute Myelogenous Leukemia (AML)
- +5 more
- Conditioning Chemotherapy
- Cord blood graft
-
Basking Ridge, New Jersey
- +6 more
May 22, 2023
MDS (MDS), Beta-thalassemia, Myeloproliferative Tumor(MPN)-Associated Myelofibrosis Trial in Worldwide (Luspatercept)
Recruiting
- Myelodysplastic Syndromes (MDS)
- +2 more
-
Los Angeles, California
- +203 more
Jan 30, 2023
MDS (MDS), Acute Myelogenous Leukemia (AML) Trial in United States (low dose 5'-azacitidine)
Active, not recruiting
- Myelodysplastic Syndromes (MDS)
- Acute Myelogenous Leukemia (AML)
- low dose 5'-azacitidine
-
Basking Ridge, New Jersey
- +6 more
Dec 1, 2022
Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), MDS (MDS) Trial in New York (other, radiation, drug)
Recruiting
- Acute Myeloid Leukemia (AML)
- +2 more
- Personalized rATG (P-rATG)
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 31, 2022
Acute Myeloid Leukemia (AML), MDS (MDS) Trial in China (APG-115, Azacitidine, Cytarabine)
Recruiting
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndromes (MDS)
- APG-115
- +2 more
-
Beijing, Beijing, China
- +13 more
Aug 16, 2022
MDS (MDS) Trial in United Kingdom (Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol)
Recruiting
- Myelodysplastic Syndromes (MDS)
- Sodium Valproate, Bezafibrate, Medroxyprogesterone
- Danazol
-
Dudley, England, United Kingdom
- +7 more
Aug 12, 2022
MDS (MDS) Trial in Worldwide (Azacitidine, Venetoclax)
Active, not recruiting
- Myelodysplastic Syndromes (MDS)
-
Tucson, Arizona
- +36 more
Aug 1, 2022
B-Cell Lymphoma, MDS (MDS), Acute Myeloid Leukemia (AML) Trial in Houston (Cyclophosphamide, CAR.70/IL15-transduced CB-NK cells,
Not yet recruiting
- B-Cell Lymphoma
- +2 more
- Cyclophosphamide
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 12, 2022
MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Huddinge, Uppsala (NEX-18a injection,
Terminated
- Myelodysplastic Syndromes (MDS)
- +2 more
- NEX-18a injection
- Azacitidine Injection
-
Huddinge, Sweden
- +1 more
Apr 4, 2022
The National Myelodysplastic Syndromes (MDS) Study
Recruiting
- Myelodysplastic Syndromes (MDS)
- Therapeutic
-
Anaheim, California
- +280 more
Apr 8, 2022
MDS (MDS) Trial in United States (Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine)
Completed
- Myelodysplastic Syndromes (MDS)
- Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine
-
Chicago, Illinois
- +11 more
Apr 4, 2022
Acute Myeloid Leukaemia (AML), MDS (MDS) Trial in Germany, Netherlands (Panobinostat)
Active, not recruiting
- Acute Myeloid Leukaemia (AML)
- Myelodysplastic Syndromes (MDS)
-
Stuttgart, Baden-Württemberg, Germany
- +18 more
Dec 13, 2021
MDS (MDS) Trial in United States (Panobinostat)
Terminated
- Myelodysplastic Syndromes (MDS)
-
Fort Myers, Florida
- +6 more
Nov 18, 2021
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- +7 more
- Cyclophosphamide
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 8, 2021
Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory
Recruiting
- Myeloid Leukemia, Chronic
- +8 more
- Conventional T cells (Tcon) and Regulatory T cells (Treg)
-
Palo Alto, CaliforniaStanford University School of Medicine Palo Alto, California, Un
Aug 18, 2021
Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Atlanta, Houston (K-NK002, Conditioning Regimen, HaploBMT)
Withdrawn
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndromes (MDS)
- K-NK002
- +2 more
-
Atlanta, Georgia
- +1 more
Jun 16, 2021
A Prospective, Multicentre European Registry for Newly Diagnosed
Recruiting
- Myelodysplastic Syndromes (MDS)
- No interventions
-
Innsbruck, Austria
- +17 more
Dec 28, 2020
MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Japan (Panobinostat)
Completed
- Myelodysplastic Syndromes (MDS)
- +2 more
-
Nagoya-city, Aichi, Japan
- +5 more
Dec 16, 2020
Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), MDS (MDS) Trial in Worldwide (Treosulfan)
Completed
- Acute Lymphoblastic Leukaemias (ALL)
- +3 more
-
Vienna, Austria
- +23 more
Apr 30, 2020
Myelodysplastic Syndromes Under Different Treatment Modalities
Completed
- Myelodysplastic Syndromes (MDS)
- +4 more
-
Aachen, Germany
- +12 more
Feb 20, 2020
MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML) Trial in United States (Subcutaneous (SC)
Completed
- Myelodysplastic Syndromes (MDS)
- +2 more
- Subcutaneous (SC) Azacitidine
- Oral Azacitidine
-
Gainesville, Florida
- +17 more
Nov 6, 2019
Neural Tube Defects, Anemia, Leukemia, Myeloid Trial in Stanford (CIK cells, Cyclosporine, Mycophenolate Mofetil)
Completed
- Neural Tube Defects
- +5 more
- CIK cells
- +4 more
-
Stanford, CaliforniaStanford University School of Medicine
Apr 18, 2019
MDS (MDS), Acute Myeloid Leukaemia (AML) Trial in Belgium, Germany, United Kingdom (Autologous WT1 TCR transduced T cells)
Completed
- Myelodysplastic Syndromes (MDS)
- Acute Myeloid Leukaemia (AML)
- Autologous WT1 TCR transduced T cells
-
Brugge, Belgium
- +5 more
Oct 1, 2018